ConductScience.org, home

Paper7684524

Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group.

Prostate, 1993. Cited by 140 papers, by iCite.

Cite this record

ConductScience Library. Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group. Papers, record 7684524. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7684524

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group.
PubMed
Journal
Prostate
PubMed
Year
1993
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
140
iCite
Relative citation ratio, by iCite
5.83
iCite
Revised in PubMed
2019-09-13
PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
5-alpha Reductase InhibitorsMajor topic
AndrostenesMajor topic
AzasteroidsMajor topic
Prostatic HyperplasiaMajor topic
Aged
Aged, 80 and over
Dihydrotestosterone
Double-Blind Method
Drug Tolerance
Finasteride
Humans
Male
Middle Aged
Prostate
Prostate-Specific Antigen
Testosterone
Ultrasonography
Urination

Source PubMed

Download CSV of topics

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.

PMIDTitleJournalYearIn PapersSource
38243941Neurokinin B Administration Induces Dose Dependent Proliferation of Seminal Vesicles in Adult Rats.Curr Protein Pept Sci2024https://conductscience.org/library/papers/38243941PubMed
37994101Salvia miltiorrhiza Bunge Ameliorates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress via Nrf-2/HO-1 Activation.J Microbiol Biotechnol2024https://conductscience.org/library/papers/37994101PubMed
34747724Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis.Asian J Androl2022https://conductscience.org/library/papers/34747724PubMed
32314009The impact of 5-alpha-reductase inhibitors on mortality in a prostate cancer chemoprevention setting: a meta-analysis.World J Urol2021https://conductscience.org/library/papers/32314009PubMed
29531971BCL-2 and BCL-XL expression are down-regulated in benign prostate hyperplasia nodules and not affected by finasteride and/or celecoxib.Am J Clin Exp Urol2018https://conductscience.org/library/papers/29531971PubMed
28800482Targeting phenotypic heterogeneity in benign prostatic hyperplasia.Differentiation2017https://conductscience.org/library/papers/28800482PubMed
28795417Molecular pathogenesis of human prostate basal cell hyperplasia.Prostate2017https://conductscience.org/library/papers/28795417PubMed
27529214Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia.Int J Mol Sci2016https://conductscience.org/library/papers/27529214PubMed
26546040Isolation and analysis of discreet human prostate cellular populations.Differentiation2016https://conductscience.org/library/papers/26546040PubMed
26307022The many ways to make a luminal cell and a prostate cancer cell.Endocr Relat Cancer2015https://conductscience.org/library/papers/26307022PubMed
25032191Current role of treatment in men with lower urinary tract symptoms combined with overactive bladder.Prostate Int2014https://conductscience.org/library/papers/25032191PubMed
23570837Androgen receptor roles in the development of benign prostate hyperplasia.Am J Pathol2013https://conductscience.org/library/papers/23570837PubMed
21826125Medical treatment of benign prostatic hyperplasia.Rev Urol2011https://conductscience.org/library/papers/21826125PubMed
21031091The different reduction rate of prostate-specific antigen in dutasteride and finasteride.Korean J Urol2010https://conductscience.org/library/papers/21031091PubMed
20927745Finasteride for benign prostatic hyperplasia.Cochrane Database Syst Rev2010https://conductscience.org/library/papers/20927745PubMed
20126609Pathophysiology of benign prostatic hyperplasia: insights from medical therapy for the disease.Rev Urol2009https://conductscience.org/library/papers/20126609PubMed
19756467[Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)].Urologe A2009https://conductscience.org/library/papers/19756467PubMed
19707263Finasteride in the treatment of patients with benign prostatic hyperplasia: a review.Ther Clin Risk Manag2009https://conductscience.org/library/papers/19707263PubMed
19296071[Treatment of LUTS in BPS. When and when not to administer pills?].Urologe A2009https://conductscience.org/library/papers/19296071PubMed
19252137Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.J Clin Oncol2009https://conductscience.org/library/papers/19252137PubMed

See all 42 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7684524

GET https://conductscience.org/api/papers/v1/7684524/cited_by?page=2